Literature DB >> 16401643

Efficient nonviral gene delivery into primary lymphocytes from rats and mice.

Christine Goffinet1, Oliver T Keppler.   

Abstract

A rapid method for efficient gene delivery into primary rodent lymphocytes would greatly facilitate the study of signaling and metabolic pathways in untransformed hematopoietic cells as well as the validation of gene expression and targeting strategies before the generation of knockout or knock-down animals. Here, we report that species-adapted nucleofection procedures combined with optimized cultivation conditions render proliferating primary T cells, B cells, and natural killer cells from widely used rat and mouse strains susceptible to high-level gene delivery. As a result, transgene expression levels were enhanced approximately 10- to 370-fold over established protocols. The effectiveness of the nucleofection approach for functional analyses was demonstrated by specific down-regulation of CD4 cell surface molecules by either transient expression of the endocytosis-inducing Nef protein from human immunodeficiency virus or by specific gene silencing mediated by small interfering RNA. In conclusion, this species-adapted procedure for nonviral gene delivery renders primary rodent lymphocytes accessible to rapid functional ex vivo studies, which until now have not been feasible. Furthermore, nucleofection may aid the advancement of therapeutic nonviral gene delivery approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401643     DOI: 10.1096/fj.05-4651fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Authors:  Christine Goffinet; Ina Allespach; Oliver T Keppler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

2.  Efficient transfection of primary zebrafish fibroblasts by nucleofection.

Authors:  Rossen Badakov; Anna Jaźwińska
Journal:  Cytotechnology       Date:  2006-09-21       Impact factor: 2.058

3.  Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.

Authors:  A Özgül Tezgel; Gabriela Gonzalez-Perez; Janice C Telfer; Barbara A Osborne; Lisa M Minter; Gregory N Tew
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

4.  High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.

Authors:  Hanna-Mari Tervo; Oliver T Keppler
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Mapping Optimal Charge Density and Length of ROMP-Based PTDMs for siRNA Internalization.

Authors:  Leah M Caffrey; Brittany M deRonde; Lisa M Minter; Gregory N Tew
Journal:  Biomacromolecules       Date:  2016-09-21       Impact factor: 6.988

6.  Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Authors:  Christine Goffinet; Sarah Schmidt; Christian Kern; Lena Oberbremer; Oliver T Keppler
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

7.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

8.  Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells.

Authors:  Brittany M deRonde; Joe A Torres; Lisa M Minter; Gregory N Tew
Journal:  Biomacromolecules       Date:  2015-09-14       Impact factor: 6.988

9.  Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo.

Authors:  Christine Goffinet; Ina Allespach; Lena Oberbremer; Pamela L Golden; Scott A Foster; Brian A Johns; Jason G Weatherhead; Steven J Novick; Karen E Chiswell; Edward P Garvey; Oliver T Keppler
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Targeted delivery of siRNA to cell death proteins in sepsis.

Authors:  Pavan Brahmamdam; Eizo Watanabe; Jacqueline Unsinger; Katherine C Chang; William Schierding; Andrew S Hoekzema; Tony T Zhou; Jacquelyn S McDonough; Heather Holemon; Jeremy D Heidel; Craig M Coopersmith; Jonathan E McDunn; Richard S Hotchkiss
Journal:  Shock       Date:  2009-08       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.